Clinical trial · Observational
Efficacy of Patient Management for Lymphoma Diagnosed at Nimes University Hospital From 1999 to 2018. DVR-Lym-Nim
Evaluation of the Efficacy of Management of Patients With Lymphomas Diagnosed at Nimes University Hospital Over 20 Years (1999-2018) Under Real-life Circumstances
NCT04947618CI-TRIAL-00115113DVR-Lym-NimterminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 10, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260910-000001
Why stopped (as posted): The doctor retired and there's no one to take over the project
Summary
Brief summary (as posted)
Observation of a cohort of 400 patients with different types of lymphomas.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lymphoma, Malignant | Lymphoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (6)
- measure
- Overall survival rate among patients with Hodgkin Lymphomas
- timeFrame
- 2 years after inclusion
- description
- The number of months during which the patient has survived since inclusion will be noted. If the patient has died, the date of death recorded in the hospital file or from the INSERM CépiDC register will be noted.
- measure
- Overall survival rate among patients with Mantle-cell Lymphomas
- timeFrame
- 2 years after inclusion
- description
- The number of months during which the patient has survived since inclusion will be noted.If the patient has died, the date of death recorded in the hospital file or from the INSERM CépiDC register will be noted.
- measure
- Overall survival rate among patients with Primitive Cerebral Lymphomas
- timeFrame
- 2 years after inclusion
- description
- The number of months during which the patient has survived since inclusion will be noted. If the patient has died, the date of death recorded in the hospital file or from the INSERM CépiDC register will be noted.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 15 Years
Show eligibility criteria text
Inclusion Criteria: * Patients over the age of 15 years and 3 months, diagnosed with lymphoma at Nîmes University Hospital as from 1999 onwards and for whom diagnostic tumor material is available. Exclusion Criteria: * Patients aged 18 or over who have expressed their desire not to take part in the study. * Patients under the age of 18 whose legal representatives have expressed their desire for the child not to take part in the study. * Patients under legal guardianship.
References
Publications (0)
Data not yet available
No reference posted for this study.